Education
About Us
Working with TipRanks
Follow Us
Cooper Co (COO)
NASDAQ:COO
COO Stock Chart & Stats
$81.38
-$0.81(-0.88%)
At close: 4:00 PM EST
$81.38
-$0.81(-0.88%)
Day’s Range― - ―
52-Week Range$61.78 - $97.21
Previous CloseN/A
Volume244.93K
Average Volume (3M)1.90M
Market Cap
$15.95B
Enterprise Value$18.85B
Total Cash (Recent Filing)$124.90M
Total Debt (Recent Filing)$2.48B
Price to Earnings (P/E)43.4
Beta0.72
Next Earnings
Feb 26, 2026EPS Estimate
1.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.15
Shares Outstanding195,978,030
10 Day Avg. Volume1,790,730
30 Day Avg. Volume1,903,027
Financial Highlights & Ratios
PEG Ratio-7.35
Price to Book (P/B)1.70
Price to Sales (P/S)3.42
P/FCF Ratio32.24
Enterprise Value/Market Cap1.18
Enterprise Value/Revenue4.66
Enterprise Value/Gross Profit6.96
Enterprise Value/Ebitda17.28
Forecast
1Y Price Target
$90.42Price Target Upside11.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)4.52
Revenue Forecast (FY)$4.32B
Bulls Say, Bears Say
Bulls Say
Cost Savings And Cash Flow ImprovementManagement expects pretax integration-related savings of $50 million in FY26 and has raised multi-year free cash flow targets, supporting margin improvement and potential for higher shareholder returns.
Product Regulatory ProgressRegulatory approval or other progress for the SightGlass myopia-management spectacles could create a new commercial growth opportunity if commercialization succeeds.
Strategic Review And Corporate SeparationFormal strategic review that could lead to separating CooperVision and CooperSurgical or pursuing divestitures and partnerships may unlock shareholder value by creating more focused, standalone businesses.
Bears Say
Competitive Pressure From StellestCompetition from EssilorLuxottica’s Stellest spectacles could pressure MiSight’s market share and slow contact-lens growth, increasing revenue uncertainty.
Revenue Guidance ShortfallRevenue guidance that was slightly below Street expectations could signal slower top-line momentum and dampen near-term investor sentiment.
Cooper Co News
COO FAQ
What was Cooper Co’s price range in the past 12 months?
Cooper Co lowest stock price was $61.77 and its highest was $97.21 in the past 12 months.
What is Cooper Co’s market cap?
Cooper Co’s market cap is $15.95B.
When is Cooper Co’s upcoming earnings report date?
Cooper Co’s upcoming earnings report date is Feb 26, 2026 which is in 25 days.
How were Cooper Co’s earnings last quarter?
Cooper Co released its earnings results on Dec 04, 2025. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.113 by $0.037.
Is Cooper Co overvalued?
According to Wall Street analysts Cooper Co’s price is currently Undervalued.
Does Cooper Co pay dividends?
Cooper Co pays a Semiannually dividend of $0.007 which represents an annual dividend yield of N/A. See more information on Cooper Co dividends here
What is Cooper Co’s EPS estimate?
Cooper Co’s EPS estimate is 1.03.
How many shares outstanding does Cooper Co have?
Cooper Co has 195,978,030 shares outstanding.
What happened to Cooper Co’s price movement after its last earnings report?
Cooper Co reported an EPS of $1.15 in its last earnings report, beating expectations of $1.113. Following the earnings report the stock price went up 5.673%.
Which hedge fund is a major shareholder of Cooper Co?
Currently, no hedge funds are holding shares in COO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cooper Co Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$90.42 (11.11% Upside)
$90.42 (11.11% Upside)
Blogger Sentiment
Bullish
COO Sentiment 75%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 26.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 9.8%
Last 30 Days ▼ 9.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.04%
12-Months-Change
Fundamentals
Return on Equity
4.59%
Trailing 12-Months
Asset Growth
0.65%
Trailing 12-Months
Company Description
Cooper Co
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
COO Company Deck
COO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The company's earnings call reflected a focus on strong financial performance and strategic growth initiatives. While CooperVision and the share repurchase program showed significant positive trends, challenges in certain markets, particularly in China and the fertility segment, posed some concerns.View all COO earnings summariesCOO Net sales Breakdown
67.05% CooperVision
32.95% CooperSurgical
COO Stock 12 Month Forecast
Average Price Target
$90.42
▲(11.11% Upside)
Technical Analysis
Ownership Overview
0.57% Insiders
36.78% Mutual Funds
0.75% Other Institutional Investors
36.19% Public Companies and
Individual Investors